Pennant Investors »

Arcturus Therapeutics Hldg I shares owned by Pennant Investors

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $442k 13k 33.77

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
BlackRock
BlackRock
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
ARK Investment Management
State Street Corporation
Vanguard Group
Morgan Stanley
Dimensional Fund Advisors
Woodline Partners
Geode Capital Management
Portolan Capital Management
Goldman Sachs Group
Schonfeld Strategic Advisors

View all funds holding Arcturus Therapeutics Hldg I